• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

GW Cancer receives $4 million award for technical assistance to comprehensive cancer control

Bioengineer by Bioengineer
March 27, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control Program (NCCCP) grantees. These programs are in all 50 states, Washington, D.C., eight tribes and tribal organizations, and seven U.S. Associated Pacific Islands/territories. The new five-year award is a competitive renewal of the successful $2.1 million awarded from 2013 to 2018.

The cooperative agreement expands technical assistance efforts by leveraging the existing infrastructure, capacity and relationships of the talent at the institute for patient centered initiatives & health equity, a division of the GW Cancer Center, to provide support to NCCCP grantees. NCCCP grantees create stakeholder-driven plans that aim to reduce the burden of cancer through evidence-based cancer control interventions adapted to local settings, including efforts to advance access to screening, treatment, and cancer survivorship care and to reduce health inequities.

The GW Cancer Center’s strategies include:

    – Improved mechanisms of communication and coordination

    – Web-based professional education and training with continuing education credits

    – Development, maintenance and dissemination of tools and resources

    – Identification and dissemination of successful policy, systems, and environmental changes

    – Coalition-building and strategic planning for NCCCPs

    – Live workshops focused on American Indian tribes and Pacific Island Jurisdiction needs

“The GW Cancer Center is pleased to continue supporting Comprehensive Cancer Control programs through this award. I am extremely proud of the technical assistance team. CDC’s renewal of our work demonstrates the high value placed on our tailored, multi-level strategies to advance cancer control and reduce health inequities across the nation,” said Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center. “We look forward to another strong half decade with this exciting and rewarding project.”

The five-year project will receive $825,000 per year, totaling $4.125 million after five years of funding, subject to availability of funds. The project is 100 percent federally financed, with zero percent of financing from non-government sources.

###

Media Contact
Lisa Anderson
[email protected]
https://cancercenter.gwu.edu/news/investigator-receives-4125-million-award-continue-technical-assistance-comprehensive-cancer

Tags: cancerHealth CareHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthPublic Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Natural P450 Variants Influence Aedes Dengue Susceptibility

Natural P450 Variants Influence Aedes Dengue Susceptibility

August 12, 2025
blank

Breakthrough Protein Therapy Emerges as First-Ever Antidote for Carbon Monoxide Poisoning

August 12, 2025

RSDR RNA Shields Kidneys via hnRNPK-Ferroptosis Pathway

August 12, 2025

New Multidimensional COPD Diagnosis Uncovers Previously Overlooked At-Risk Patients

August 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    78 shares
    Share 31 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Natural P450 Variants Influence Aedes Dengue Susceptibility

RSNA AI Challenge Models Demonstrate Independent Mammogram Interpretation Capabilities

Breakthrough Protein Therapy Emerges as First-Ever Antidote for Carbon Monoxide Poisoning

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.